Shilpa Medicare: US FDA audit has been completed at its API sites at Raichur District, Karnataka between 3rd and 7th Feb, 2020 with "ZERO" observations
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum
SHILPAMED Share Price Discussion
Shilpa Medicare Ltd.
NSE: SHILPAMED | BSE: 530549 | ISIN: INE790G01031 | Sector: Pharmaceuticals and health care
SHILPAMED Rating
- ★★
- ★★
- ★★
- ★★
- ★★
5/5 (1 Ratings)
SHILPAMED Share Price *
461 +21.95 (5%)
* (quote may be delayed)
Find answers to all your questions on live SHILPAMED message board: Is SHILPAMED buy or sell? Should I buy SHILPAMED shares? Why are SHILPAMED shares falling? Should I invest in SHILPAMED stock?
You can also check SHILPAMED share price target recommended by brokerages.
SHILPAMED Discussion Forum
@ygtrader • Reputation: 1,690
ElliottWave Master in SHILPAMEDTarget met! Strong returns
Posted to buy at
304.5
Made highs of 410
Over 100+ points.
Like
reply
Reply
@ygtrader • Reputation: 1,690
ElliottWave Master in SHILPAMEDSHILPAMEDTrade entered: Buy SHILPAMED @304.5 Target@320 ...
Target met!
Strong returns
Like
reply
Reply
@newsbot • Reputation: 2,308
Shilpa Medicare share price gains nearly 6% on USFDA nod
The company has received USFDA tentative approval for its ANDA Pirfenidone tablets.
The company has received USFDA tentative approval for its ANDA Pirfenidone tablets.
Moneycontrol
Like
reply
Reply
@stocktrendr • Reputation: 319
Shilpa Medicare: Company gets tentative US FDA nod for generic of Esbriet drug
Like
reply
Reply
@newsbot • Reputation: 2,308
Stocks in the news: M&M, Maruti, Coal India, Tata Motors, Alkem Labs, Indian Bank
Relaxo Footwears | Thyrocare Technologies | Infoedge | Indian Bank | Mahindra & Mahindra | Maruti | Alkem Labs are some of the stocks which are in news today.
Relaxo Footwears | Thyrocare Technologies | Infoedge | Indian Bank | Mahindra & Mahindra | Maruti | Alkem Labs are some of the stocks which are in news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
Stocks in the news: HUL, ITC, Divis Lab, Castrol, Power Grid, JSPL, IndoStar Capital
HUL | ITC | Vedanta | Castrol | Power Grid | Amara Raja Batteries and J&K Bank are among the stocks that are in the news today.
HUL | ITC | Vedanta | Castrol | Power Grid | Amara Raja Batteries and J&K Bank are among the stocks that are in the news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
Shilpa Medicare zooms 5% after USFDA concludes inspection of Telangana facility
The stock witnessed spurt in volume by more than 1.17 times. It was trading with volumes of 3,249 shares, compared to its five-day average of 1,886 shares, an increase of 72.27 percent.
The stock witnessed spurt in volume by more than 1.17 times. It was trading with volumes of 3,249 shares, compared to its five-day average of 1,886 shares, an increase of 72.27 percent.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
Stocks in the news: Canara Bank, NBCC, PNB, DHFL, Shilpa Medicare, Avenue Supermarts
Vivimed Labs | Canara Bank | DHFL | Varun Beverages and Rane Holdings are stocks, which are in news today.
Vivimed Labs | Canara Bank | DHFL | Varun Beverages and Rane Holdings are stocks, which are in news today.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
Top 10 stocks that rose or fell in the week
The S&P BSE Midcap index shed 1.31 percent, Smallcap Index was down 0.90 percent and S&P BSE Largecap Index fell 0.59 percent last week.
The S&P BSE Midcap index shed 1.31 percent, Smallcap Index was down 0.90 percent and S&P BSE Largecap Index fell 0.59 percent last week.
www.moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 2,308
Shilpa Medicare gets 5 observations from USFDA for its Raichur facility
"We have completed USFDA (United States Food and Drug Administration) audit at our API (active pharmaceutical ingredient) site, Raichur between July 22-26, 2019," Shilpa Medicare said in a filing to the BSE.
"We have completed USFDA (United States Food and Drug Administration) audit at our API (active pharmaceutical ingredient) site, Raichur between July 22-26, 2019," Shilpa Medicare said in a filing to the BSE.
www.moneycontrol.com
Like
reply
Reply
@newsbot • Reputation: 2,308
Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term
Like
reply
Reply
@newsbot • Reputation: 2,308
Shilpa Medicare gains 3% on USFDA approval for cancer drug
Like
reply
Reply
@newsbot • Reputation: 2,308
Shilpa Medicare rises 3% on USFDA approval for Imatinib Mesylate tablets
Like
reply
Reply
@newsbot • Reputation: 2,308
Shilpa Medicare gets USFDA nod for cancer treatment injection
Like
reply
Reply
@newsbot • Reputation: 2,308
Shilpa Medicare gains 3.5% after receiving FDA approval for an injection
Like
reply
Reply
@newsbot • Reputation: 2,308
Shilpa Medicare jumps 9% on USFDA nod for Dimethyl Fumarate that used for multiple sclerosis patients
Like
reply
Reply
@newsbot • Reputation: 2,308
Shilpa Medicare gets tentative USFDA nod for multiple sclerosis drug
Like
reply
Reply
@newsbot • Reputation: 2,308
Sonal Mercant Standalone September 2018 Net Sales at Rs 0.30 crore, down 27.33% Y-o-Y
Like
reply
Reply
- NewsBotFeb 3 4:03 PMShilpa Medicare share price gains nearly 6% on USFDA nodMoneycontrolNewsBotFeb 3 1:43 PMStocks in the news: M&M, Maruti, Coal India, Tata Motors, Alkem Labs, Indian BankMoneycontrolNewsBotFeb 1 1:18 PMStocks in the news: HUL, ITC, Divis Lab, Castrol, Power Grid, JSPL, IndoStar CapitalMoneycontrolNewsBotSep 9 5:28 PMShilpa Medicare zooms 5% after USFDA concludes inspection of Telangana facilityMoneycontrolNewsBotSep 9 1:43 PMStocks in the news: Canara Bank, NBCC, PNB, DHFL, Shilpa Medicare, Avenue SupermartsMoneycontrolNewsBotAug 17 6:58 PMTop 10 stocks that rose or fell in the weekwww.moneycontrol.comNewsBotJul 30 1:18 AMShilpa Medicare gets 5 observations from USFDA for its Raichur facilitywww.moneycontrol.comNewsBotApr 22 2:08 PMTop buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short termNewsBotFeb 25 4:57 PMShilpa Medicare gains 3% on USFDA approval for cancer drugNewsBotFeb 25 4:17 PMShilpa Medicare gets USFDA nod for cancer drug
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.